Will ICON’s Anthropic collaboration reduce clinical trial delays and protocol amendments?
ICON and Anthropic will build Claude-powered clinical trial tools inside Orbis, targeting site selection, enrolment risk and protocol design.
Features & Analysis
Features & Analysis
Can ICON turn governance repair into renewed momentum for clinical research services?
ICON’s restatement and backlog reset test CRO confidence as pharma sponsors weigh execution risk, trial demand and 2026 recovery signals.